{
    "2019-06-27": [
        [
            {
                "time": "2019-01-04",
                "original_text": "Pfizer names former FDA chief Scott Gottlieb to its board",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "FDA",
                        "Scott Gottlieb",
                        "board"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-15",
                "original_text": "Scott Gottlieb Elected to Pfizerâ€™s Board of Directors",
                "features": {
                    "keywords": [
                        "Scott Gottlieb",
                        "Pfizer",
                        "Board of Directors"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-10",
                "original_text": "Pfizer Declares Third-Quarter 2019 Dividend",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Dividend",
                        "Third-Quarter"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-23",
                "original_text": "Lilly's Study on Higher Doses of Trulicity Meets Endpoint",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Trulicity",
                        "Study",
                        "Higher Doses",
                        "Endpoint"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-12",
                "original_text": "Draper laboratory signs 'organ-on-chip' development deal with Bristol-Myers Squibb",
                "features": {
                    "keywords": [
                        "Draper laboratory",
                        "organ-on-chip",
                        "Bristol-Myers Squibb",
                        "development deal"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Special Committee",
                        "Glyphosate",
                        "Lawsuits"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "agriculture",
                        "chemicals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "Ex-FDA boss joins Pfizer 83 days after leaving US drug regulator",
                "features": {
                    "keywords": [
                        "Ex-FDA",
                        "boss",
                        "Pfizer",
                        "US drug regulator"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}